NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers (Q37638021)
Jump to navigation
Jump to search
scientific article published on January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers |
scientific article published on January 2013 |
Statements
1 reference
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers (English)
1 reference
1 reference
Maurizio Zangari
1 reference
Wen Zhou
1 reference
Ye Yang
1 reference
Jiliang Xia
1 reference
He Wang
1 reference
Mohamed E Salama
1 reference
Wei Xiong
1 reference
Hongwei Xu
1 reference
Shashirekha Shetty
1 reference
Tiehua Chen
1 reference
Zhaoyang Zeng
1 reference
Lei Shi
1 reference
Rodney Miles
1 reference
Guido Tricot
1 reference
Fenghuang Zhan
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference